Sutro Biopharma (STRO)

NASDAQ
5.43
-0.21(-3.72%)
After Hours
5.43
0.00(0.00%)
- Real-time Data
  • Volume:
    224,327
  • Day's Range:
    5.32 - 5.68
  • 52 wk Range:
    3.33 - 23.70

STRO Overview

Prev. Close
5.64
Day's Range
5.32-5.68
Revenue
53.12M
Open
5.61
52 wk Range
3.33-23.7
EPS
-2.89
Volume
224,327
Market Cap
283.24M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
427,521
P/E Ratio
-2.39
Beta
0.938
1-Year Change
-70.88%
Shares Outstanding
52,161,451
Next Earnings Date
Nov 10, 2022
What is your sentiment on Sutro Biopharma?
or
Market is currently closed. Voting is open during market hours.

Sutro Biopharma News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Sutro Biopharma Company Profile

Sutro Biopharma Company Profile

Employees
224

Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company’s product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials. It has collaboration and license agreements with Merck Collaboration to develop research programs focusing on cytokine derivatives for cancer and autoimmune disorders; and Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.

Read More

Analyst Price Target

Average26.75 (+392.63% Upside)
High37
Low14
Price5.43
No. of Analysts8
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellSellSell
Technical IndicatorsStrong BuyStrong BuyStrong SellSellStrong Sell
SummaryStrong BuyBuyStrong SellSellStrong Sell
  • Any news on this stock?
    0
    • did you got news ? -))) or nada ? now Tristan Davis worth to entry ?
      0